Non-interventional study Be-1st: First line therapy with bendamustine in advanced indolent non-Hodgkin lymphoma (NHL) in treatment routine. 2. Juni 2013 Becker, M., Tschechne, B., Reeb, M., Schwinger, U., Bruch, H.-R., Straßl, L., 2013. haematologica, EHA (Stockholm) 98, P321. Abstract Lifestyle Faktoren – Einfluss auf die Lebensqualität beim Mammakarzinom. Marschner, N., 2012. J Cancer Res Clin Oncol (2012) 138(Suppl 1): 1. doi:10.1007/s00432-011-1144-4 Abstract… Weiterlesen Specific adverse events predict survival benefit in patients treated with tamoxifen or aromatase inhibitors: an international tamoxifen exemestane adjuvant multinational trial analysis. Fontein, D.B.Y., Seynaeve, C., Hadji, P., Hille, E.T.M., van de Water, W., Putter, H., Kranenbarg, E.M.-K., Hasenburg, A., Paridaens, R.J., Vannetzel, J.-M., Markopoulos, C., Hozumi,… Weiterlesen